Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depressed classical complement pathway activities in chronic lymphocytic leukaemia.

G Füst, E Czink, D Minh

    Clinical and Experimental Immunology
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].

    Zeitschrift fur Gastroenterologie·2016
    Same author

    OS004. A link between the complement system and angiogenic imbalance inpreeclampsia: ficolin-2 deficiency.

    Pregnancy hypertension·2015
    Same author

    The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.

    European journal of microbiology & immunology·2014
    Same author

    Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.

    Clinical and experimental immunology·2013
    Same author

    Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.

    Genes and immunity·2012
    Same author

    Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.

    Clinical and experimental immunology·2012

    Chronic lymphocytic leukemia (CLL) patients often show reduced classical complement pathway activity. This involves low levels of C1 and C4 complement components, suggesting a frequent immune system deficiency in CLL.

    Area of Science:

    • Immunology
    • Hematology
    • Biochemistry

    Background:

    • The complement system is crucial for immune response.
    • Complement deficiencies can impact disease progression.
    • Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.

    Purpose of the Study:

    • To investigate complement pathway activity in patients with chronic lymphocytic leukemia (CLL).
    • To assess levels of specific complement components (C1, C4, C3, factor B, C1 inhibitor) in CLL patients.
    • To determine the frequency of complement pathway alterations in CLL.

    Main Methods:

    • Serum samples from 46 CLL patients were analyzed.
    • Haemolytic activities of classical and alternative complement pathways were measured.
    • Levels of C1, C4, C3, factor B, and C1 inhibitor (C1-INH) were quantified.

    Related Experiment Videos

    Main Results:

    • Significantly decreased mean C1 and C4 levels were observed in CLL patients.
    • Low or low-normal haemolytic activity of C1 and C4 was found in over 50% of samples.
    • A complement profile resembling acquired C1 inhibitor (C1-INH) deficiency was noted in some patients.

    Conclusions:

    • Depressed classical complement pathway activity is a common finding in chronic lymphocytic leukemia (CLL).
    • These alterations may contribute to the pathophysiology or clinical course of CLL.
    • Further research is warranted to understand the clinical implications of complement deficiencies in CLL.